Turbulent flow chromatog. coupled to tandem mass spectrometry (TFC-MS-MS) has been widely used within bioanal., because of the ability to inject directly neat biol. samples with no prior pretreatment.TFC-MS-MS removes the need for time consuming sample preparation procedures such as protein precipitation, liquid-liquid extraction or solid-phase extractionThere are two standard configurations that are commonly adopted for the use of TFC, namely fast elute and focus mode.In this paper, a new micro TFC column which has the advantages of reducing solvent consumption and improving mass sensitivity, was used to develop a fast elute method.A wide range of pharmaceutical compounds with various physicochem. properties was used to assess the system performance.Carry-over has often been identified as a potential source of inaccuracy in a fast elute mode.This paper shows how by using a systematic approach, carryover was eliminated.The parameters influencing the robustness of the micro TFC column are also discussed.This method was fully validated for a Pfizer development compound in human plasma using a new TFC parallel platform allowing two systems to be operated in parallel.Multiplexing the sample anal. allowed a 2-fold increase in throughput and provided an efficient use of the mass spectrometer.